See more : Puriblood Medical Co., Ltd. (6847.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China National Electric Apparatus Research Institute Co., Ltd., a leading company in the Electrical Equipment & Parts industry within the Industrials sector.
- Motive Capital Corp II (MTVC) Income Statement Analysis – Financial Results
- PennyMac Mortgage Investment Trust (PMT-PA) Income Statement Analysis – Financial Results
- Qomel Co. (9600.SR) Income Statement Analysis – Financial Results
- Athena Consumer Acquisition Corp. (ACAQ-UN) Income Statement Analysis – Financial Results
- PixarBio Corporation (PXRB) Income Statement Analysis – Financial Results
China National Electric Apparatus Research Institute Co., Ltd. (688128.SS)
About China National Electric Apparatus Research Institute Co., Ltd.
China National Electric Apparatus Research Institute Co., Ltd. provides solution in the fields of quality and technology services, intelligent equipment, environmental-friendly coatings, and polyester resins. The company offers quality and technical services, including testing, certifications, standardization, calibrations, inspections, proficiency testing, laboratory technical, and training services in the areas of smart homes, intelligent vehicles, 5G communications, intelligent equipment, healthcare, consumer goods, and rail traffic. It also provides intelligent home appliance factory one-stop solutions, excitation systems, automatic testing systems of new energy battery, power electronics equipment, intelligent equipment for automobiles, and AS/RS and logistics systems. In addition, the company offers polyester resins, and powder and liquid coatings. The company was founded in 1958 and is based in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.17B | 3.79B | 3.41B | 2.52B | 2.75B | 2.60B | 1.94B | 1.58B |
| Cost of Revenue | 2.91B | 2.72B | 2.48B | 1.73B | 1.85B | 1.83B | 1.37B | 1.10B |
| Gross Profit | 1.26B | 1.08B | 931.82M | 794.08M | 900.24M | 772.08M | 570.73M | 480.69M |
| Gross Profit Ratio | 30.20% | 28.45% | 27.35% | 31.52% | 32.71% | 29.72% | 29.38% | 30.40% |
| Research & Development | 323.02M | 287.51M | 247.19M | 208.92M | 214.48M | 199.24M | 162.07M | 141.35M |
| General & Administrative | 45.84M | 42.12M | 36.32M | 26.65M | 37.59M | 31.27M | 117.82M | 131.20M |
| Selling & Marketing | 286.25M | 231.94M | 207.02M | 153.68M | 223.92M | 199.18M | 170.21M | 153.17M |
| SG&A | 332.09M | 274.06M | 243.34M | 180.33M | 261.51M | 230.44M | 288.03M | 284.37M |
| Other Expenses | 150.96M | 125.83M | 107.89M | 102.61M | 101.07M | 1.63M | -4.99M | 57.39M |
| Operating Expenses | 806.07M | 687.40M | 598.42M | 491.86M | 577.05M | 499.21M | 422.18M | 439.14M |
| Cost & Expenses | 3.72B | 3.40B | 3.07B | 2.22B | 2.43B | 2.32B | 1.79B | 1.54B |
| Interest Income | 30.24M | 24.31M | 21.35M | 5.89M | 5.40M | 2.37M | 766.95K | 3.60M |
| Interest Expense | 7.17M | 9.10M | 7.32M | 2.73M | 2.48M | 1.81M | 0.00 | 9.05M |
| Depreciation & Amortization | 143.20M | 121.68M | 107.18M | 72.16M | 61.14M | 62.37M | 58.77M | 68.50M |
| EBITDA | 604.06M | 514.80M | 459.60M | 386.74M | 337.82M | 298.64M | 188.88M | 228.47M |
| EBITDA Ratio | 14.48% | 14.21% | 13.99% | 15.45% | 13.81% | 12.45% | 10.25% | 15.58% |
| Operating Income | 454.28M | 380.45M | 346.34M | 306.26M | 280.40M | 226.60M | 128.64M | 91.61M |
| Operating Income Ratio | 10.89% | 10.03% | 10.16% | 12.16% | 10.19% | 8.72% | 6.62% | 5.79% |
| Total Other Income/Expenses | -362.16K | 1.68M | 4.84M | 3.23M | -3.02M | 2.50M | -4.99M | 57.39M |
| Income Before Tax | 453.91M | 382.14M | 351.90M | 308.96M | 277.38M | 229.10M | 123.64M | 149.00M |
| Income Before Tax Ratio | 10.88% | 10.07% | 10.33% | 12.26% | 10.08% | 8.82% | 6.37% | 9.42% |
| Income Tax Expense | 45.70M | 24.05M | 39.19M | 25.74M | 21.87M | 18.83M | 12.33M | 17.35M |
| Net Income | 410.09M | 363.31M | 315.06M | 282.71M | 252.17M | 206.91M | 111.90M | 131.00M |
| Net Income Ratio | 9.83% | 9.57% | 9.25% | 11.22% | 9.16% | 7.96% | 5.76% | 8.29% |
| EPS | 1.01 | 0.90 | 0.78 | 0.70 | 0.62 | 0.58 | 0.39 | 0.62 |
| EPS Diluted | 1.01 | 0.90 | 0.78 | 0.70 | 0.62 | 0.58 | 0.39 | 0.62 |
| Weighted Avg Shares Out | 406.03M | 404.50M | 404.50M | 404.50M | 404.50M | 356.74M | 286.92M | 211.28M |
| Weighted Avg Shares Out (Dil) | 406.03M | 404.50M | 404.50M | 404.50M | 404.50M | 356.74M | 286.92M | 211.28M |
Source: https://incomestatements.info
Category: Stock Reports